The DEA has rescheduled the epilepsy cannabidiol drug Epidiolex, paving the way to market for the cannabis-based treatment.
from WebMD Health https://ift.tt/2xWMdBi
The DEA has rescheduled the epilepsy cannabidiol drug Epidiolex, paving the way to market for the cannabis-based treatment.
0 comments:
Post a Comment